Michael Secora insider trades
Open-market stock purchases and sales by Michael Secora, CFO & Chief Corp Dev Ofcr at Iambic Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2021.
Open-market stock purchases and sales by Michael Secora, CFO & Chief Corp Dev Ofcr at Iambic Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2021.